Vivek Ramaswamy
About Vivek Ramaswamy
Vivek Ramaswamy is the co-founder of Strive Asset Management and the founder of Roivant Sciences, with a strong background in biotechnology and finance. He is known for his advocacy against ESG investing and has authored a book on the subject.
Work at Roivant Sciences
Vivek Ramaswamy founded Roivant Sciences in 2014 and served as the Chief Executive Officer until 2021. During his tenure, he oversaw the development of five drugs that received FDA approval. His leadership contributed to the company's focus on innovative biopharmaceutical solutions. Ramaswamy's experience in biotechnology and pharmaceuticals played a significant role in shaping Roivant's strategic direction.
Current Role at Strive Asset Management
Since 2022, Ramaswamy has served as Co-Founder of Strive Asset Management. The firm, based in Ohio, aims to compete with major asset managers such as BlackRock, State Street, and Vanguard. Ramaswamy's vision for Strive includes a focus on investment strategies that align with conservative values, positioning the firm as a competitor in the asset management industry.
Education and Expertise
Ramaswamy studied at Harvard University, where he earned an A.B. degree in Biology from 2003 to 2007. He also attended Yale Law School, obtaining a Doctor of Law (J.D.). His educational background has provided him with a strong foundation in both the life sciences and legal frameworks, enhancing his expertise in the biotechnology and financial sectors.
Background and Early Career
Before founding Roivant Sciences, Ramaswamy worked at QVT Financial LP as a Partner from 2007 to 2014. His experience in finance and investment management contributed to his understanding of the intersection between healthcare and capital markets. Ramaswamy's early career laid the groundwork for his later ventures in biotechnology and asset management.
Achievements and Recognition
Ramaswamy has authored the book 'Capitalist Punishment: How Wall Street is Using Your Money to Create a Country You Didn’t Vote For.' He has gained recognition as a prominent figure in the anti-ESG movement, being described as the 'right’s leading anti-ESG crusader' by Axios and Bloomberg. Additionally, he has been characterized by Politico as one of the 'intellectual godfathers of the anti-woke movement.'